Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Allurion Technologies, Inc. Common Stock (NY: ALUR )

0.3480 +0.0681 (+24.33%)
Official Closing Price Updated: 7:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 744,341
Open 0.3200
Bid (Size) 0.3300 (20)
Ask (Size) 0.3500 (79)
Prev. Close 0.2799
Today's Range 0.2801 - 0.3564
52wk Range 0.2600 - 4.000
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance
From Allurion Technologies, Inc.
Via Business Wire

Performance

YTD
-90.14%
-90.14%
1 Month
-31.88%
-31.88%
3 Month
-44.36%
-44.36%
6 Month
-81.68%
-81.68%
1 Year
-90.20%
-90.20%

More News

Read More
Why Vision Marine Technologies Shares Are Trading Higher By 34%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Earnings Scheduled For November 13, 2024
Via Benzinga
A Look Ahead: Allurion Technologies's Earnings Forecast
Via Benzinga
Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program
From Allurion Technologies, Inc.
Via Business Wire
12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Allurion Reports Third Quarter 2024 Financial Results and Provides Business Update
From Allurion Technologies, Inc.
Via Business Wire
Allurion Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society’s Annual Conference
From Allurion Technologies, Inc.
Via Business Wire
Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024
From Allurion Technologies, Inc.
Via Business Wire
Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon
From Allurion Technologies, Inc.
Via Business Wire
12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session
Via Benzinga
Allurion Announces Publication of New Data Demonstrating Muscle Mass Preservation in Patients Experiencing 15% Weight Loss
From Allurion Technologies, Inc.
Via Business Wire
12 Consumer Discretionary Stocks Moving In Monday's After-Market Session
Via Benzinga
October's 4 Best Penny Stocks: High-Risk, High-Reward Picks
Via MarketBeat
Topics Bankruptcy
Exposures Financial Legal
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Allurion Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight Loss
From Allurion Technologies, Inc.
Via Business Wire
Allurion Receives Continued Listing Standards Notice from NYSE
From Allurion Technologies, Inc.
Via Business Wire
Allurion Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from Obesity
From Allurion Technologies, Inc.
Via Business Wire
Allurion Announces the Appointment of Eli Lilly Veteran, Keith Johns, to Its Board of Directors
From Allurion Technologies, Inc.
Via Business Wire
12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Allurion Announces Publication of New Data Demonstrating Continued Weight Loss at One Year On the Allurion Program
From Allurion Technologies, Inc.
Via Business Wire
Allurion Announces the Appointment of Adrian Wild as Senior Vice President, International Commercial
From Allurion Technologies, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.